The impact of glutamine cycling on brain function has been highlighted by the recent discovery of rare biallelic variants in SLC38A3 [109], resulting in global developmental delay, microcephaly, epilepsy, absent speech and visual impairment. This evidence concerns the gene SLC38A3 and epilepsy.